(Q89391950)

English

Gastric cancer

scientific article published on 05 May 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

Europe PubMed Central

Gastric cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Eric Van Cutsem

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Xavier Sagaert

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Baki Topal

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Karin Haustermans

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

language of work or name

0 references

publication date

5 May 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

388

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

10060

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

2654-2664

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Global patterns of cardia and non-cardia gastric cancer incidence in 2012.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Esophageal adenocarcinoma incidence: are we reaching the peak?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Helicobacter pylori-induced gastric inflammation and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term follow up of patients treated for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial gastric cancer: genetic susceptibility, pathology, and implications for management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hereditary diffuse gastric cancer: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fruit and vegetable consumption and gastric cancer by location and histological type: case–control and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Smoking and gastric cancer: systematic review and meta-analysis of cohort studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of adenocarcinoma of the oesophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of gastric carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive molecular characterization of gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic instabilities in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu amplification is an independent prognostic factor in gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylation subtypes and large-scale epigenetic alterations in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Unmet needs and challenges in gastric cancer: the way forward

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portu

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrence after curative resection of early gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Laparoscopy-assisted versus open distal gastrectomy for early gastric cancer: evidence from randomized and nonrandomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Laparoscopic gastrectomy for advanced gastric cancer: are the long-term results comparable with conventional open gastrectomy? A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer G

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestiv

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted HER2 treatment in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930354-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(16)30354-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27156933%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q89391950&oldid=1398274714"